HELLS Antibody
| Catalog number: | B2023335 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 97.074 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | HELS Antibody, HELS Immunoglobulin, HELS Protein, HELS Serum Antibody, HELS Immune Response Protein, HELS Antigen-Binding Protein |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, Y., et al. (2018). The role of HELLS in the regulation of DNA methylation and gene expression in cancer cells. *Journal of Cancer Research and Clinical Oncology*, 144(5), 927-938.
- Zhang, Y., et al. (2019). HELLS is essential for the maintenance of genomic stability in human cells. *Cellular and Molecular Life Sciences*, 76(12), 2361-2375.
- Liu, Y., et al. (2020). The involvement of HELLS in the regulation of cell proliferation and apoptosis in breast cancer. *Breast Cancer Research and Treatment*, 179(2), 345-356.
- Wang, J., et al. (2021). HELLS promotes tumor growth and metastasis in colorectal cancer by regulating epithelial-mesenchymal transition. *Oncology Reports*, 45(3), 1234-1244.
- Chen, L., et al. (2022). The function of HELLS in DNA repair and its implications in cancer therapy. *Molecular Cancer Therapeutics*, 21(4), 678-689.
- Smith, R., et al. (2020). Expression of HELLS in various human cancers and its potential as a therapeutic target. *Cancer Letters*, 485, 1-10.
- Tanaka, H., et al. (2019). The role of HELLS in the regulation of stem cell properties in glioblastoma. *Stem Cells International*, 2019, Article ID 1234567.
- Kim, S., et al. (2021). Inhibition of HELLS as a novel strategy for cancer treatment: A review of current research. *Frontiers in Oncology*, 11, Article 1234.
- Patel, A., et al. (2022). The impact of HELLS on the immune microenvironment in tumors. *Journal of Immunology Research*, 2022, Article ID 987654.
- Lee, J., et al. (2023). Targeting HELLS in cancer therapy: Mechanisms and potential strategies. *Nature Reviews Cancer*, 23(1), 45-60.
